EFS
Essex Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $344K | Sell |
772
-5
| -0.6% | -$2.23K | 0.02% | 509 |
|
|
2025
Q1 | $377K | Sell |
777
-24
| -3% | -$11.6K | 0.03% | 441 |
|
|
2024
Q4 | $323K | Sell |
801
-155
| -16% | -$62.4K | 0.02% | 473 |
|
|
2024
Q3 | $454K | Buy |
956
+219
| +30% | +$104K | 0.03% | 399 |
|
|
2024
Q2 | $343K | Buy |
737
+60
| +9% | +$28K | 0.03% | 450 |
|
|
2024
Q1 | $283K | Buy |
677
+37
| +6% | +$15.5K | 0.03% | 434 |
|
|
2023
Q4 | $260K | Sell |
640
-11
| -2% | -$4.48K | 0.03% | 425 |
|
|
2023
Q3 | $226K | Sell |
651
-9
| -1% | -$3.13K | 0.03% | 421 |
|
|
2023
Q2 | $232K | Sell |
660
-21
| -3% | -$7.39K | 0.03% | 415 |
|
|
2023
Q1 | $215K | Sell |
681
-52
| -7% | -$16.4K | 0.02% | 456 |
|
|
2022
Q4 | $211K | Buy |
733
+11
| +2% | +$3.17K | 0.02% | 448 |
|
|
2022
Q3 | $209K | Sell |
722
-26
| -3% | -$7.53K | 0.02% | 428 |
|
|
2022
Q2 | $211K | Sell |
748
-76
| -9% | -$21.4K | 0.02% | 451 |
|
|
2022
Q1 | $215K | Buy |
+824
| New | +$215K | 0.02% | 464 |
|